Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis

Home

News

Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis

Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsis

Written by Critical Care

Monday, 18 January 2010 18:00

not application

Authors: Leonardo Lorente

Read More: Critical Care - Latest Articles

Tags

Related Articles

A plethora of angiopoietin-2 effects during clinical sepsis ? - 16/06/2010
Antenatal anaesthetic assessment of the pregnant woman - 30/06/2010
Assessment of monocytic HLA-DR expression in ICU patients: analytical issues for multicentric flow cytometry studies - 26/07/2010
Atrial fibrillation is not just an artefact n ICU - 21/07/2010
Bending the cost curve in the United States: The role of comparative effectiveness research - 21/06/2010

You need to login or register to post comments.

Discuss...

Acute and Critical Care

Foundation Degree

Latest Articles

Latest Downloads